Autori: Abella Esteban
| Naslov | FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis. (Meeting Abstract) |
| Autori | Siefker-Radtke Arlene O Currie Graeme Abella Esteban Vaena Daniel A Kalebasty Arash Rezazadeh Curigliano Giuseppe Tupikowski Krzysztof Andric Zoran G  Lugowska Iwona Kelly William Kevin
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
